Puma Biotechnology | PBYI - Ebitda





Ebitda Alterar Data
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amgen USD 5.14B 775M 2025-12
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Exelixis USD 258.29M 15.43M 2026-03
Gilead Sciences USD 3.02B 1.01B 2025-12
Glaxosmithkline GBP 2.77B 1.98B 2026-03
Incyte USD 367.97M 46.53M 2026-03
MacroGenics USD -30.2M 52.15M 2026-03
Moderna USD -790M 582M 2025-12
Novartis USD 6.48B 1.19B 2026-06
Pfizer USD 5.99B 5.23B 2026-03
PTC Therapeutics USD -70.99M 91.62M 2025-12
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 13.43B 744M 2026-06
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
Takeda JPY 150.25B 297.88B 2026-03
TG Therapeutics USD 51.69M 19M 2025-12
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03